Health workers in Japan are looking to new tools to fight COVID-19 as the country faces an eighth wave of infections.
Doctors have started prescribing an oral drug available for low-risk patients.
The Japanese government gave emergency approval of Xocova last week. The first domestically developed oral drug is made by pharmaceutical firm Shionogi.
Doctors say it's difficult to predict who COVID will hit hard. They wanted a drug they could prescribe more broadly.
The government plans to provide hospitals across the nation with enough doses for one million patients.
Health officials approved on Monday public sales of antigen test kits that can simultaneously check for the coronavirus and seasonal influenza.
Doctors have started prescribing an oral drug available for low-risk patients.
The Japanese government gave emergency approval of Xocova last week. The first domestically developed oral drug is made by pharmaceutical firm Shionogi.
Doctors say it's difficult to predict who COVID will hit hard. They wanted a drug they could prescribe more broadly.
The government plans to provide hospitals across the nation with enough doses for one million patients.
Health officials approved on Monday public sales of antigen test kits that can simultaneously check for the coronavirus and seasonal influenza.
◆hit hard 大きな打撃・衝撃を与える to be badly affected by something that has happened
◆antigen test kits 抗原検査キット